AntimicrobialInvestigational

Iseganan (IB-367)

Oral rinse

Overview

Iseganan is a 17-amino acid synthetic analog of protegrin, a naturally occurring antimicrobial peptide found in porcine leukocytes. It disrupts microbial cell membranes via a beta-sheet structure stabilized by disulfide bonds, conferring broad-spectrum activity against bacteria, fungi, and some viruses.

Mechanism of Action

Iseganan was developed primarily as an oral rinse to prevent ventilator-associated pneumonia and oral mucositis in immunocompromised patients. Its rapid microbicidal action and low systemic absorption profile supported its formulation for topical oral use..

Research Summary & Key Findings

Phase III trials in ventilator-associated pneumonia prevention did not meet primary endpoints for reducing infection rates, leading to discontinuation of development for that indication. Studies in chemotherapy-induced oral mucositis similarly failed to demonstrate significant clinical benefit. Development was halted in the early 2000s following these trial results.

Clinical Status

Investigational

Iseganan (IB-367) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Oral rinse

Related Peptides in Antimicrobial

Find a Provider

Find a verified provider who offers Iseganan (IB-367) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Iseganan (IB-367).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.